Instituto de Oftalmología Aplicada de Valladolid-ko ikertzaileekin lankidetzan egindako argitalpenak (6)

2022

  1. CHARACTERIZING COVID-19-RELATED RETINAL VASCULAR OCCLUSIONS: A Case Series and Review of the Literature

    Retina (Philadelphia, Pa.), Vol. 42, Núm. 3, pp. 465-475

  2. Efficacy, safety and cost-effectiveness of methotrexate, adalimumab or their combination in non-infectious non-anterior uveitis: a protocol for a multicentre, randomised, parallel three arms, active-controlled, phase III open label with blinded outcome assessment study

    BMJ open, Vol. 12, Núm. 3, pp. e051378

2021

  1. Recommendations for ophthalmologic practice during the easing of COVID-19 control measures

    Acta Ophthalmologica, Vol. 99, Núm. 7, pp. e973-e983

2018

  1. Retinal toxicity of medical devices used during vitreoretinal surgery: A critical overview

    Ophthalmologica, Vol. 240, Núm. 4, pp. 236-243

2017

  1. Acute retinal damage after using a toxic perfluoro-octane for vitreo-retinal surgery

    Retina, Vol. 37, Núm. 6, pp. 1140-1151

2012

  1. A propensity score matching application: Indications and results of adding scleral buckle to vitrectomy: The Retina 1 project: Report 3

    European Journal of Ophthalmology, Vol. 22, Núm. 2, pp. 244-253